Clarity Pharmaceuticals (Clarity Pharmaceuticals) Accounts Payable : $2.67 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Clarity Pharmaceuticals Accounts Payable?

Clarity Pharmaceuticals's Accounts Payable for the quarter that ended in Dec. 2023 was $2.67 Mil.

Clarity Pharmaceuticals's quarterly Accounts Payable declined from Dec. 2022 ($4.69 Mil) to Jun. 2023 ($1.91 Mil) but then increased from Jun. 2023 ($1.91 Mil) to Dec. 2023 ($2.67 Mil).

Clarity Pharmaceuticals's annual Accounts Payable increased from . 20 ($0.00 Mil) to Jun. 2022 ($2.00 Mil) but then declined from Jun. 2022 ($2.00 Mil) to Jun. 2023 ($1.91 Mil).

Clarity Pharmaceuticals Accounts Payable Historical Data

The historical data trend for Clarity Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarity Pharmaceuticals Accounts Payable Chart

Clarity Pharmaceuticals Annual Data

Trend

Jun22

Jun23

Accounts Payable

2.00

1.91

Clarity Pharmaceuticals Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial			1.42	2.00	4.69	1.91	2.67

Clarity Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Clarity Pharmaceuticals Accounts Payable Related Terms

Thank you for viewing the detailed overview of Clarity Pharmaceuticals's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Clarity Pharmaceuticals (Clarity Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clarity Pharmaceuticals Ltd (OTCPK:CLRPF) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

CU6:Australia

Address

4 Cornwallis Street, National Innovation Centre, Eveleigh, Sydney, NSW, AUS, 2015

Website

https://www.claritypharmaceuticals.com

Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology.